Literature DB >> 1513476

Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Clinical measures.

.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1513476

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects.

Authors:  J Gerritsen; B J TenVoorde; J M Dekker; R Kingma; P J Kostense; L M Bouter; R M Heethaar
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

2.  Quantitative sensory testing of thermal and vibratory perception in familial dysautonomia.

Authors:  M J Hilz; F B Axelrod
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

3.  Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.

Authors:  Catherine L Martin; Barbara H Waberski; Rodica Pop-Busui; Patricia A Cleary; Sarah Catton; James W Albers; Eva L Feldman; William H Herman
Journal:  Diabetes Care       Date:  2010-09-10       Impact factor: 19.112

Review 4.  Diabetic neuropathy in the elderly.

Authors:  A A Sima; D A Greene
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

5.  Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.

Authors:  Joseph C Arezzo; Julio Rosenstock; Linda Lamoreaux; Lynne Pauer
Journal:  BMC Neurol       Date:  2008-09-16       Impact factor: 2.474

6.  Peripheral sensory neuropathy in type 2 diabetes patients: A case control study in Accra, Ghana.

Authors:  Kwame Yeboah; Peter Puplampu; Vincent Boima; Daniel A Antwi; Ben Gyan; Albert G B Amoah
Journal:  J Clin Transl Endocrinol       Date:  2016-07-20

7.  Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.

Authors:  Sheyu Li; Xiang Chen; Qianrui Li; Juan Du; Zhimin Liu; Yongde Peng; Mian Xu; Qifu Li; Minxiang Lei; Changjiang Wang; Shaoxiong Zheng; Xiaojuan Zhang; Hongling Yu; Jinyu Shi; Shibing Tao; Ping Feng; Haoming Tian
Journal:  J Diabetes Investig       Date:  2016-03-28       Impact factor: 4.232

8.  Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study.

Authors:  Aaron Yarlas; Andrew Lovley; Duncan Brown; Mark Kosinski; Montserrat Vera-Llonch
Journal:  J Neurol       Date:  2021-06-14       Impact factor: 4.849
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.